FDA rejects Alkermes’ NDA for antidepressant drug

This article was originally published here

The US Food and Drug Administration (FDA) has rejected Alkermes’ new drug application (NDA) for antidepressant drug, ALKS 5461.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply